RecallRadar

FDA Device recall Z-0056-2013

AutoMate 1250 and AutoMate 2550, Part Numbers ODL25125 and ODL25255

On 2012-10-24 the FDA classified a Class II recall of AutoMate 1250 and AutoMate 2550, Part Numbers ODL25125 and ODL25255 by Beckman Coulter, citing the recall was initiated because Beckman Coulter has confirmed customer reports of secondary tubes being labeled with two different barcode labels on the AutoMate 2500 Family (pre….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0056-2013
ClassificationClass II
Statusterminated
Initiated2012-04-11
Published2012-10-24
Last updated2026-09-13 11:53 UTC
CompanyBeckman Coulter
DistributionUS

Product

AutoMate 1250 and AutoMate 2550, Part Numbers ODL25125 and ODL25255. The AutoMate 1200/2500 System Series is a semi-open, pre- and post-analytical sample processing and sorting system. The base system automates the sample sorting, decapping, and archiving processes. Handling and sorting of samples includes automatic detection of the tube type and cap type (color). Optional features include an Aliquot Module for creation of labeled secondary tubes (including the detection of the presence of adequate volume for the requested aliquots) and a Recapper Module to re-seal previously decapped tubes prior to archiving.

Reason

The recall was initiated because Beckman Coulter has confirmed customer reports of secondary tubes being labeled with two different barcode labels on the AutoMate 2500 Family (previously referred to as OLA2500 Systems) units which can cause misidentification of a sample when software versions lower than version 4.1 is used.

Identifiers

code_infoAll Serial Numbers

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0056-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.